Clinical Trials Logo

Clinical Trial Summary

This randomized, double-blinded, cross-over study aim to evaluate the effects of shunt treatment in idiopathic normal pressure hydrocephalus (iNPH) by measuring cerebral ventricular volume and clinical symptoms at different shunt opening pressures. Further, proteins in the cerebrospinal fluid (CSF) will be compared before and after shunt surgery.


Clinical Trial Description

The participants are evaluated before surgery and one month, two months, three months and three months plus one day after surgery. At each evaluation point a MRI of the brain with volumetric sequences is performed and clinical data is collected (Walking speed and steps for Time up and go, 10m walking and 3m walking backwards. Mini Mental State Examination, balance, gait, self rating of incontinence, Epworth Sleepiness Scale). At surgery, all patients are given a ventriculoperitoneal (VP) shunt (Strata ® ) with an opening pressure setting of 1.5. After the first evaluation, one month postoperatively, participants are randomized to either a higher (2.5) or a lower (1.0) opening pressure, ratio 1:1. The opening pressure setting is blinded both for patients and the clinician during the subsequent clinical evaluations. At two months, the opening pressure is crossed over to the alternative setting (2.5 or 1.0). At three months, all participants receive the lowest shunt opening pressure (0.5) with the final evaluation the next day. Semiautomatic measurement of the lateral as well as the third cerebral ventricles will be performed using the MRI scans and volumetric software: SyMRI (SyntheticMR AB, Linköping, Sweden) CSF is collected at three times for each participant, from the lumbar spine pre- and 3 months postoperatively and intracranially during surgery. Further, intracranial CSF is taken through the Rickham Reservoir at the 3 months postoperative evaluation. After CSF from the participants has been collected, a single batch mass spectrometry will be performed with all the samples simultaneously. Sample size was determined to achieve 80% power for a two tailed paired t-test for a mean change in ventricular volume of 8ml, estimated from postoperative change in ventricular volume in a previous study. Hypotheses: - The volume of the ventricular system in the brain decreases significantly after shunt-surgery. - The ventricular volume is larger at high opening pressures compared to low opening pressures of the shunt. - The decrease in ventricular volume is related to clinical outcome. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04599153
Study type Interventional
Source Uppsala University
Contact
Status Completed
Phase N/A
Start date October 10, 2017
Completion date October 28, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT06083233 - Role of Brain Specific Biomarkers in Hydrocephalus N/A
Active, not recruiting NCT04785560 - Volumetrics and Proteomics in Shunted Normal Pressure Hydrocephalus N/A
Recruiting NCT05250505 - Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus N/A
Terminated NCT03076723 - Using Cerebrospinal Fluid Dynamics to Optimize Treatment of Idiopathic Normal Pressure Hydrocephalus N/A
Recruiting NCT04011566 - Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus
Recruiting NCT04309487 - Diagnostic Accuracy of ShuntCheck Compared to Radionuclide Shunt: Patency in Patients With Normal Pressure Hydrocephalus
Completed NCT02659111 - Effects of Physical Training in iNPH N/A
Completed NCT01850914 - Vascular Risk Factors in INPH-patients N/A
Completed NCT01115270 - A Study Comparing Shunt Placement Versus Endoscopic Third Ventriculostomy in the Treatment of Hydrocephalus N/A
Completed NCT05204745 - Ventriculomegaly and Gait Disturbance in the Senior Population in the Region of Västerbotten
Recruiting NCT05232838 - US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus N/A